Position in CRDF
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$830,307
+$181,375 QoQ
Shares Held
638,699
+59.4% QoQ
Ownership
0.821%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#8
of 104 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in CRDF Over Time
Shares Held
Position Value (USD)
Derivatives in CRDF
reported options exposure · as of Sep 30, 2025CallValue
$1,303,980
CallShares
633,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026UBS Group AG holds $8,789,675,801 across 560 Biotechnology names. CRDF ranks #274 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
5,450,825 | $1,020,369,609 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
17,466,641 | $618,144,423 | |
| 3 | PTGX |
Protagonist Therapeutics, Inc
|
3,399,221 | $416,676,508 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
712,259 | $353,800,411 | |
| 5 | MRNA |
Moderna, Inc.
|
4,463,211 | $312,558,664 | |
| 6 | INSM |
INSMED Inc
|
2,584,446 | $275,553,630 | |
| 7 | ABVX |
Abivax S.A.
|
1,844,918 | $245,853,771 | |
| 8 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
401,708 | $215,697,109 |
All Filings in CRDF
Export CSV
31 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $830,307 | 638,699 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $648,932 | 400,576 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $245,674 | 87,429 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $424,719 | 206,175 | Shares | Defined | 2025-11-13 | |
| 2025-09-30 | $1,303,980 | 633,000 | Call | Defined | 2025-11-13 | |
| 2025-06-30 | $1,993,950 | 633,000 | Call | Defined | 2025-08-14 | |
| 2025-06-30 | $621,929 | 197,438 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,987,620 | 633,000 | Call | Defined | 2025-05-13 | |
| 2025-03-31 | $271,719 | 86,535 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $2,747,220 | 633,000 | Call | Defined | 2025-02-14 | |
| 2024-12-31 | $1,229,746 | 283,352 | Shares | Defined | 2025-02-14 | |
| 2024-12-31 | $130,200 | 30,000 | Put | Defined | 2025-02-14 | |
| 2024-09-30 | $1,690,110 | 633,000 | Call | Defined | 2024-11-14 | |
| 2024-09-30 | $129,665 | 48,564 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $1,405,260 | 633,000 | Call | Defined | 2024-08-14 | |
| 2024-06-30 | $93,162 | 41,965 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $3,380,220 | 633,000 | Call | Defined | 2024-05-13 | |
| 2024-03-31 | $15,816 | 2,962 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $4,965 | 3,355 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $86 | 63 | Shares | Defined | 2023-11-09 | |
| 2023-06-30 | $5,605 | 3,814 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $25,887 | 15,690 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $7,958 | 5,685 | Shares | Defined | 2023-02-08 | |
| 2022-09-30 | $13,004 | 8,445 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $92 | 42 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $17,320 | 6,984 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $72,504 | 12,064 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $22,377 | 3,360 | Shares | Sole | 2021-11-15 | |
| 2020-12-31 | $11,405 | 634 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $53,623 | 3,779 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $22,654 | 4,522 | Shares | Defined | 2020-07-31 | |
| No filing history on record for this holder in this stock. | ||||||